Efficacy of Prostat in the treatment of NIH category IIIA prostatitis.
- Author:
Hongtao YAN
1
;
Yong LIAO
;
Baisheng GONG
;
Zhaoxiang CHEN
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Humans; Male; Middle Aged; Phytotherapy; Pollen; Prostatitis; drug therapy; Treatment Outcome
- From: National Journal of Andrology 2004;10(12):930-931
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo evaluate the efficacy of Prostat in the treatment of NIH category IIIA prostatitis.
METHODSAn open clinical trial was conducted among 106 NIH category IIIA prostatitis patients. For each patient 1 tablet of Prostat (70 mg P5 + 4 mg EA10) was orally administered twice a day.
RESULTSSubjective symptoms of the patients were significantly improved, particularly those of frequent micturition, urgent urination and peripheral region pains. Objective parameters also showed significant improvement. No adverse reaction associated with the medication was observed.
CONCLUSIONProstat was shown to be an appropriate medicine in the treatment of NIH category IIIA prostatitis, with good curative effect and high safety.
